Resmed Inc. buy Morgan Stanley
Start price
21.10.25
/
50%
€230.40
Target price
21.10.26
€261.08
Performance (%)
-9.98%
Price
23.12.25
€207.40
Summary
This prediction is currently active. With a performance of -9.98%, the BUY prediction by Morgan_Stanley is trending in the wrong direction. This prediction currently runs until 21.10.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | -1.050% | -1.050% |
| iShares Core DAX® | 1.732% | 4.638% |
| iShares Nasdaq 100 | 3.304% | 0.517% |
| iShares Nikkei 225® | 2.342% | 0.972% |
| iShares S&P 500 | 2.357% | 0.872% |
Comments by Morgan_Stanley for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) had its price target raised by analysts at Morgan Stanley from $298.00 to $304.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat